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Stably Transfected Common Fragile Site Sequences
Exhibit Instability at Ectopic Sites
Ryan L. Ragland, Michael W. Glynn, Martin F. Arlt, Thomas W. Glover*
Departmentof HumanGenetics,Universityof Michigan,Ann Arbor,MI
Common fragile sites (CFSs) are loci that are especially prone to forming gaps and breaks on metaphase chromosomes under
conditions of replication stress. Although much has been learned about the cellular responses to gaps and breaks at CFSs, less
is known about what makes these sites inherently unstable. CFS sequences are highly conserved in mammalian evolution and
contain a number of sequence motifs that are hypothesized to contribute to their instability. To examine the role of CFS
sequences in chromosome breakage, we stably transfected two BACs containing FRA3B sequences and two nonCFS control
BACs containing similar sequence content into HCT116 cells and isolated cell clones with BACs integrated at ectopic sites.
Integrated BACs were present at just a few to several hundred contiguous copies. Cell clones containing integrated FRA3B
BACs showed a significant, three to sevenfold increase in aphidicolin-induced gaps and breaks at the integration site as com-
pared to control BACs. Furthermore, many FRA3B integration sites displayed additional chromosome rearrangements associ-
ated with CFS instability. Clones were examined for replication timing and it was found that the integrated FRA3B sequences
were not dependent on late replication for their fragility. This is the first direct evidence in human cells that introduction of
CFS sequences into ectopic nonfragile loci is sufficient to recapitulate the instability found at CFSs. These data support the hy-
pothesis that sequences at CFSs are inherently unstable, and are a major factor in the formation of replication stress induced
gaps and breaks at CFSs. VC 2008 Wiley-Liss, Inc.
INTRODUCTION
Common fragile sites (CFSs) are chromosomal
loci that are especially prone to forming cytoge-
netically visible gaps and breaks on metaphase
chromosomes under conditions of replication stress
such as treatment with low concentrations of the
DNA polymerase inhibitor aphidicolin (APH)
(reviewed in (Durkin and Glover, 2007)). These
sites span several hundred kilobases to over a meg-
abase in size with gaps and breaks occurring
throughout the region and many are located within
or span large genes. In addition to cytogenetically
identifiable gaps and breaks, CFSs exhibit a num-
ber of other characteristics of unstable DNA in cul-
tured cells including gross chromosome deletions
(Wang et al., 1993), smaller submicroscopic dele-
tions (Durkin et al., 2008), translocations (Glover
and Stein, 1988), intrachromosomal gene amplifica-
tions (Coquelle et al., 1997), and sister chromatid
exchanges (Glover and Stein, 1987). In cells pre-
treated with APH, CFSs are also preferred sites for
the integration of transfected DNA (Rassool et al.,
1991). Despite their instability, CFSs are found in
all individuals and are a normal component of the
human genome. Furthermore, CFSs are conserved
in mammalian evolution (Soulie and De Grouchy,
1981; Elder and Robinson, 1989; Smeets and van
de Klundert, 1990; Stone et al., 1991; McAllister
and Greenbaum, 1997; Glover et al., 1998; Ruiz-
Herrera et al., 2004) and counterparts exist in yeast
(Roeder and Fink, 1980; Dunham et al., 2002;
Lemoine et al., 2005).
Although CFSs are normally stable in somatic
cells in vivo, these sites are frequently rearranged
in many cancer cell lines (Arlt et al., 2002; Huebner
and Croce, 2003; Finnis et al., 2005). For example,
the two most frequently expressed CFSs, FRA3B,
and FRA16D are associated with the large tumor
suppressor genes fragile histidine triad (FHIT) and
WW domain-containing oxidoreductase (WWOX)
respectively (Boldog et al., 1994; Wilke et al., 1994;
Ohta et al., 1996; Ried et al., 2000; Bednarek et al.,
2001). Heterozygous or homozygous deletion of
these tumor suppressors is found early in tumori-
genesis and is associated with a number of differ-
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ent cancers (Ohta et al., 1996; Michael et al., 1997;
Huebner and Croce, 2003; Bartkova et al., 2005;
Gorgoulis et al., 2005). It was recently shown that
cells treated with APH form tumor-like deletions
at a high frequency at FRA3B, supporting the hy-
pothesis that such deletions are a result of replica-
tion stress (Durkin et al., 2008).
In recent years, a number of genes involved in
the intra-S and G2/M checkpoints have been
found to be important in maintaining the stability
of CFSs, including ATR, BRCA1, CHK1, FANCD2,
HUS1, and SMC1 (Casper et al., 2002; Arlt et al.,
2004; Howlett et al., 2005; Musio et al., 2005; Dur-
kin et al., 2006; Zhu and Weiss, 2007). In addition,
several genes (RAD51, DNA-PKcs, and LIG4) that
are involved in both homologous recombination
and nonhomologous end joining DNA repair path-
ways have also been reported to be involved in the
maintenance of CFSs stability (Schwartz et al.,
2005). The importance of the ATR pathway in the
maintenance of CFSs implicates stalled replication
forks as having a central role in the instability of
these sites. Although these studies have provided a
basic understanding of the DNA damage response
pathways involved in the maintenance of CFS
instability, little is understood about what makes
CFSs exceptionally susceptible to DNA damage.
There are a number of factors that could contrib-
ute to CFS instability. Primary among these is
sequence. Although it is possible that a single
sequence motif is responsible for the instability
seen at CFSs, none of the cloned CFSs contain
expanded di or trinucleotide repeats like those that
are responsible for the instability seen at rare frag-
ile sites (reviewed in (Sutherland, 2003)). In addi-
tion, gaps and breaks can occur throughout the
large CFS regions, suggesting that if sequence con-
tributes to instability it would most likely result
from one or more motifs that are present through-
out the entire CFS region. One sequence motif
that is in accordance with this hypothesis is the
flexibility peak. Flexibility peaks are defined as
sequences that have a high local variation in DNA
twist angle as measured using the TwistFlex pro-
gram (Mishmar et al., 1998). Many CFSs contain a
high number of flexibility peaks and it has been
suggested that the formation of abnormal DNA
structures at these sites during replication could be
a causal factor in their instability (Boldog et al.,
1997; Mishmar et al., 1998; Arlt et al., 2002; Mirkin
and Mirkin, 2007). In support of this hypothesis, it
has recently been shown that in yeast, an AT-rich
sequence containing variable stretches of perfect
AT repeats taken from a flexibility peak found in
the human FRA16D CFS can cause fork stalling
and chromosome breakage (Zhang and Freuden-
reich, 2007). It has also been suggested that other
sequence motifs such as high repetitive element
content may contribute to the instability of CFSs
(Rozier et al., 2004). Finally, because CFSs are
some of the latest sites in the genome to complete
replication with some sites remaining unreplicated
into the G2 phase of the cell cycle, late replication
timing may also be causal to the instability of CFSs
(Le Beau et al., 1998; Hellman et al., 2000; Palako-
deti et al., 2004).
In experiments designed to determine the con-
tribution of sequence to CFS instability, we
addressed the question of whether the integration
of BAC clones containing sequences from FRA3B
are sufficient to recapitulate CFS-like instability at
a novel genomic location. We found that cell clones
containing either of two adjacent FRA3B BACs
integrated at unique nonfragile site loci retained
CFS-like instability at the ectopic sites. In addi-
tion, we found that the fragility of integrated CFS
sequences was not dependent on late replication.
MATERIALS ANDMETHODS
Identification and Retrofitting of BACs
The Research Genetics (Huntsville, Alabama.)
human genomic BAC library was screened using
PCR probes for BAC clones containing sequence
from intron 4, exon 5, and intron 5 of FHIT. PCR
primers were designed using sequences obtained
from the UCSC Genome Browser. E. coli contain-
ing the BACs were inoculated into 1L LB media
containing 25 lg/ml chloramphenicol and incu-
bated overnight at 378C. The pRetroES plasmid
was used for retrofitting the BACs to contain neo-
mycin resistance gene following the procedures
outlined by Wang et al. (2001). Lysis and extraction
of the BAC was done following the standard CsCl
extraction protocols (Wilson, 2001). PFGE analysis
was performed on extracted BACs digested with
NotI to determine if correct retrofitting had
occurred. To determine the exact sequence con-
tent of the genomic inserts end sequencing was
preformed using T7 and SP6 primers flanking the
genomic insert in the BAC.
Sequence Analysis
Flexibility peaks were defined and determined
using the TwistFlex program (http://margalit.huji.
ac.il/TwistFlex/Home.html), which analyzes DNA
flexibility at the twist angle. Repetitive element
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content (SINEs, LINEs, LTR elements, and DNA
elements) was measured and defined using the
repeat masker program (http://www.repeatmasker.
org). Additionally, the online programs Palindrome
(http://bioweb.pasteur.fr/seqanal/interfaces/palindrome.
html), Inverted Repeat Finder (Warburton et al.,
2004), and Tandem Repeat Finder (Benson, 1999)
were used for examination of BAC sequence.
Default settings for all values for all programs were
used.
Transfection
HCT116 cells were transfected using the
DOTAP liposomal transfection reagent (Roche
Applied Science). A 10 cm2 cell culture plate was
seeded with 1.5 3 106 cells and incubated over-
night at 378C. Ten micrograms of supercoiled BAC
DNA was subsequently transfected into these
cells following the manufacturer’s protocols. The
medium was replaced after 10 hr of incubation
with selective medium containing 500 lg/ml of
active G418 (Gibco). Stable G418 resistant clones
were cloned and analyzed for integration of the
BAC by real time PCR and fluorescent in situ
hybridization.
Cell Culture and Fragile Site Analysis
HCT116 cells were grown in Dulbecco’s modi-
fied essential medium containing 10% fetal bovine
serum, L-glutamine, and penicillin/streptomycin at
378C and 5% CO2. Cells resistant for G418 were
grown as above with medium supplemented with
500 lg/ml G418.
Cells were treated with 0.4 lM APH for 24 hr
before metaphase chromosome harvest to induce
fragile site expression. Metaphases were harvested
by treating the cells with 50 ng/ml colcemid for 45
min. Cells were then placed in 0.075 M KCl at
378C for 18 min and fixed in Carnoy fixative (3:1
methanol:glacial acetic acid) for 2 hr before replac-
ing the fixative several times. Fixed cells were
dropped on slides and aged at room temperature
for 48 hr before FISH analysis.
Fifty metaphases from each cell clone were
scored for total chromosome gaps and breaks as
well as gaps and breaks at the sites of FISH probe
hybridization. To account for the differences in
treatment from one sample to another, gaps and
breaks at the sites of FISH probe hybridization
were normalized using total gaps and breaks per
cell.
FISH
The BACs used for transfection were used for
FISH analysis of the clones containing those
BACs. Established FISH protocols were followed
(Wilke et al., 1996). Probes were labeled with bio-
tin 14-dATP using the BioNic translation kit (Invi-
trogen, Carlsbad, CA). Bound probe was detected
using fluorescein isothiocynate conjugated avidin-
DCS (Vector Laboratories, Burlingame, CA) fol-
lowed by fluorescein conjugated anti-avidin IgG
(IgG). Chromosomes were stained using 40,6-dia-
midino-2-phenylindole (DAPI; Vector Laborato-
ries, Burlingame, CA). Fluorescent signals were
detected using a Zeiss Axioscope epifluorescence
microscope.
Reduction of Copy Number
To reduce the copy number of the BACs at the
sites of integration, cells were treated with a retro-
virus, AdCre1, expressing Cre recombinase (Dr.
Frank Graham McMaster University, Hamilton,
Ontario, Canada). One well of a six well plate was
seeded with 8 3 104 cells. Cells were allowed to
settle overnight and then treated with the retrovi-
rus. Cells were allowed to recover for 48 hr and
treated with retrovirus again as earlier. After the 48
hr of recovery, cells were plated out at 200 cells/
10 cm2 for the isolation of cell clones.
Quantitative Real Time PCR
Copy number of transfected BACs was esti-
mated by genomic real time PCR using the SYBR
green assay and the iCycler system (BIO RAD).
Genomic DNA was extracted by standard alkaline
lysis, and about 50 ng of total genomic DNA was
used per PCR reaction. Primers were designed
using primer 3 (http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3_www.cgi). All primer pairs were
optimized using a standard curve of 200 ng, 20 ng,
2 ng, and 0 ng samples of normal HCT116 and/or
LD055 genomic DNA. Experimental samples
were run in triplicate over two separate experi-
ments for a total of six replicates for each primer
pair and eighteen replicates for each clone. A
GAPDH primer pair was run for each sample in
triplicate over two experiments to determine total
DNA input for each sample. All results were ana-
lyzed for copy number using the 22DDct method
(Livak and Schmittgen, 2001).
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RESULTS
Characterization and Retrofitting of CFS
and Control BACs
Two BAC clones, 431E5 and 530G4, containing
genomic inserts within the FHIT gene were cho-
sen for these experiments. These two BACs are
located in the center of fragility of the most fre-
quently expressed CFS, FRA3B, and overlap by
14.5 kb (Fig. 1). FRA3B BAC 431E5 is 135.8 kb in
length, has 62% AT content, 45% repetitive ele-
ment content, contains four flexibility peaks, and
11 perfect AT repeats greater than or equal to
(AT)5 in size (Table 1). The FRA3B BAC 530G4 is
150.7 kb in size, has 62% AT content, 39% repeti-
tive element content, contains eight flexibility
peaks, and seven perfect ATrepeats greater than or
equal to (AT)5 in size.
Two control BACs taken from regions not con-
taining CFSs were chosen to match the sequence
content of the FRA3B BACs. Control BAC 250G12
is located at 10q25.1, which does not contain any
known genes, is 109.9 kb in size, has 62% AT con-
tent, 48% repetitive element content, contains four
flexibility peaks, and has 12 perfect AT repeats
greater than or equal to (AT)5. Control BAC 412D20
is located in intron 2 of the large gene, FERM do-
main-containing protein 4A (FRMD4A) at 10p13, is
79 kb in size, has 56% AT content, 39% repetitive
element content, but contains no flexibility peaks
and only two perfect AT repeats greater than or
equal to (AT)5 in size. All four BACs were examined
for the additional sequence motifs of inverted
repeats, palindromes, and tandem repeats all of
which are capable of forming strong secondary struc-
tures. Both FRA3B and control BACs contain a sim-
ilar number of tandem repeats and palindromes (Ta-
ble 1). However, control BAC 412D20 contains four
times the number of inverted repeats as the experi-
mental BACs, whereas control BAC 250G12 has
only half the number of inverted repeats.
All BACs were retrofitted to be resistant to
geneticin (G418) using the pRetroES plasmid as
described by Kim et al., (1998) (Supplemental Fig.
1). The size, integrity, and sequence content of the
genomic inserts for all BACs was confirmed by end
sequencing and pulsed field gel electrophoresis
(Supplemental Fig. 2).
The two FRA3B BACs and two control BACs
were stably transfected into HCT116 cells and
clones were selected using G418 resistance. Four
cell clones containing an integration of the FRA3B
BAC 431E5, two cell clones containing the FRA3B
BAC 530G4, four cell clones containing the control
BAC 412D20, and two cell clones containing the
control BAC 250G12 were identified (Fig. 2). Each
Figure 1. (A) Physical map of the FHIT gene and FRA3B locus. The position and size of the two FRA3B
BACs (431E5 and 530G4) is indicated. (B) Physical map of all four BAC genomic inserts. The size and
genomic location of the inserts is indicated. The number and location of flexibility peaks are indicated as
letters for each BAC. The location and size of perfect ATrepeated greater than (AT)4 is also indicated.
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clonal cell population contained a single, unique
integration site and all integration sites were cyto-
genetically distinct from any cloned CFSs.
Integrated FRA3B BACs are More Fragile Than
Control BACs
To determine if the integrated BACs retained
characteristics of CFSs, we scored total gaps and
breaks on metaphase chromosomes, gaps and
breaks specifically at the sites of integration, and at
the endogenous FRA3B loci using FISH with la-
beled BAC DNA as probe. In the absence of APH,
no clone showed a significant number of gaps and
breaks at the integration site (P value range 0.118–
1) (Fig. 3a) or at the endogenous FRA3B loci (data
not shown). Following the treatment with 0.4 lM
TABLE 1. Location and Sequence Content of the Genomic Inserts of the BACs
BAC 431E5 530G4 412D20 250G12
Type FRA3B FRA3B Control Control
Chr. 3p14.2 3p14.2 10p13 10q25
Size (kb) 135.8 150.7 79 109.9
AT (%) 61.99 62.10 56.07 62.23
Repeat Elementa (%) 44.83 38.96 39.36 48.16
SINE (%) 9.88 9.84 19.57 6.84
LINE (%) 24.42 11.37 7.90 22.95
Flex Peaks (/100 kb) 2.95 5.31 0.00 3.64
Inverted Repeats (/100 kb) 102.36 104.18 432.91 42.77
Palin.b (/100 kb) 117.08 69.01 67.09 131.94
Tandem Repeats (/100 kb) 15.46 21.90 50.63 26.39
(AT)5 (/100 kb) 8.10 4.64 2.53 10.92
aPercent of sequence that is repetitive elements.
bNumber of palindromes/100 kb of sequence.
Figure 2. (A) Representative FISH signals showing the relative size and genomic location of the BAC
insertions. (B and C) Two partial metaphase spreads demonstrating both a typical CFS-like break and a
complete chromosome break respectively, as indicated by the arrows, at the sites of integration. [Color fig-
ure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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APH, all six cell clones with integrated control
BACs showed a low frequency (0–11%) of break-
age at the integration site. This level of breakage is
not significantly different from untreated cells (P
value range 0.49–1). However, cell clones contain-
ing integrated FRA3B BACs showed a statistically
significant three to ninefold increase in gaps and
breaks at the integration site as compared to
untreated clones, and a three to sevenfold increase
in gaps and breaks at the integration site when
compared with the APH treated control cell clones
(P value range 0.023–<0.00001) (Fig. 3b). In addi-
tion, cell clones containing integrated FRA3B
BACs showed a similar, or slightly higher, level of
breakage at the ectopic integration site as com-
pared to the endogenous FRA3B loci following 0.4
lM APH treatment (Fig. 3c). Because both
FRA3B BACs were equally unstable, these results
suggest that both BACs contain sequences capable
of transferring the instability seen at the FRA3B
locus to ectopic sites in the genome.
Integrated FRA3B BACs Promote
Chromosomal Rearrangements
In addition to increased gaps and breaks on
metaphase chromosomes, eight of the twelve cell
clones containing integrated BACs displayed a va-
riety of chromosome rearrangements at the sites of
integration (Fig. 4). Cell clones containing FRA3B
BACs had a significantly (P < 0.0001) higher fre-
quency of these rearrangements as compared to
clones containing control BACs, 11.3% (72/638
metaphases) and 4.3% (27/630 metaphases),
respectively (Table 2). These include dicentric
chromosomes, ring chromosomes, laddered ampli-
cons, and massive amplification (Fig. 4 and Table
2). In addition, the FRA3B BAC 530G4 cell clone
24H3 showed a total of eight metaphases with
FISH signals exclusively on fragmented extra-
chromosomal elements, and a number of inter-
phase nuclei with micronuclei or chromatin bridge
formations (Fig. 4g,j, and k). The FRA3B BAC
431E5 cell clone 4M contained one metaphase
showing a fusion of the sister chromatids at the
integration site (Fig. 4e). The amplifications, lad-
dered FISH signal, sister chromatid fusion, and
nuclear chromatin bridges are all consistent with
breakage fusion bridge cycle (BFBC) events,
which have previously been found to be associated
with CFSs (Kuo et al., 1994; Coquelle et al., 1997,
2002).
The most striking example of this was found in
the FRA3B BAC cell clone 24H3, which demon-
strated multiple chromosomal rearrangements in-
dicative of an ongoing repair process occurring at
the integration site. In this series of metaphases,
a normal signal becomes amplified, most likely
through BFBC, and forms multiple breaks that
eventually create extra chromosomal elements
(Fig. 4f-4i). These extra chromosomal elements
are then shuttled into micronuclei for removal
from the cell (Fig. 4j-4k). Three of the six FRA3B
BAC cell clones displayed such amplifications with
multiple breaks indicating that this process is not
limited to the one clone described here.
In total, four of the six cell clones containing
FRA3B BAC integrations displayed metaphases
with rearrangements at the site of integration, and
the majority (47/74 or 63.5%) of these rearrange-
ments were of the types associated with the
BFBC. Three of the six control BAC containing
cell clones also had metaphases with rearrange-
Figure 3. Cells containing FRA3B BAC insertions show elevated
gaps and breaks at the integration site when treated with 0.4 lm APH.
All APH treated samples were normalized using total gaps and breaks
as a measure. (A) Percent of integration sites with gaps or breaks in all
untreated clones as seen in 50 metaphases for each clone. (B) The rela-
tive percentage of gaps and breaks at the site of integration after treat-
ment with 0.4 lm APH. (C) Relative percentage of gaps and breaks at
both the integration site and the endogenous FRA3B locus for each
clone.
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ments at the integration site. However, compared
to the cell clones containing FRA3B BAC integra-
tions, the control cell clones exhibited very few
rearrangements of the type associated with BFBC
events (3/27 or 11.1%), suggesting that the mecha-
nisms involved in forming the rearrangements in
the FRA3B clones are different than those in the
control clones.
The BACs Integrated in Multiple Copies
It was apparent from the size and intensity of
the FISH signals that all of the cell clones con-
tained multiple copies of the integrated BACs, pre-
sumably resulting either from integration of conca-
tamers or amplification following integration. To
determine the BAC copy number at the integration
site and to clarify whether the BACs integrated as
whole units or as fragments, we performed quanti-
tative real time PCR (Q-PCR) analysis of genomic
DNA from each clone. This analysis was per-
formed using three PCR markers for each clone,
one at either end of the genomic insert in the BAC
and one in the center.
The copy number of the integrated BACs varied
from 3 copies to over 300 copies (Table 3). For
most of the cell clones the Q-PCR values for all
three markers were not significantly different, indi-
cating that integrated BACs were present as whole
units. Although all clones contained sequence cor-
responding to all three markers, the FRA3B BAC
Figure 4. Chromosomal rearrange-
ments at the sites of BAC integrations
as seen on metaphase chromosomes.
The FISH signal indicates integrated
BAC sequence. (A) Dicentric chromo-
some observed in FRA3B BAC clone
431E5 4M. The arrows indicate the two
centromeres. (B) Ring chromosome in
control BAC clone 412D20 6H1. (C)
Ring chromosome containing multiple
FISH signals in the FRA3B BAC clone
530G4 24H3. (D) Multiple FISH signals
due to amplification in the FRA3B BAC
clone 530G4 24H3. (E) Chromosome
containing fused sister chromatids
observed in the FRA3B BAC clone
431E5 4M. (F-K) Clonal evolution of
aberrations seen in the FRA3B BAC
clone 530G4 24H3. (F) The FISH signal
seen in the majority of cells from this
clone. (G) A bridge containing multiple
FISH signals as seen between two inter-
phase nuclei. (H) A large amplification
of the integrated BAC. The laddering
seen is indicative of multiple rounds of
BFBC. (I) An example of multiple
breaks seen in the amplified region. (J)
Extrachromosomal fragments presum-
ably originating from unstable amplified
integrated BAC. (K) Micronuclei con-
taining FISH signals from multiple frag-
mented chromosomal elements.
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431E5 cell clone 11M and the control BAC
250G12 cell clone 3 contain different copy num-
bers of the three markers (Table 3). Sequence from
marker No. 1 was over-represented in both of these
clones, indicating that the BACs either did not
integrate or did not amplify as a unit. Importantly,
all of the FRA3B BAC cell clones have a similar
overall copy number as the control BAC cell
clones, with the exception of clone 8L, which con-
tained over 300 copies of the FRA3B BAC 431E5.
The frequency of gaps and breaks at integrated
FRA3B BACs was not statistically different (P
value range 0.49–1) between clones with different
copy numbers. However, analysis of the BAC copy
numbers revealed a trend whereby the fragility of
an integrated FRA3B BAC increased with copy
number. This trend was seen between the FRA3B
BAC 431E5 cell clones 7H, 4M, and 8L and
between the FRA3B BAC 530G4 cell clones 24H3
and 1H (Fig. 3). This suggests that both sequence
content and copy number contribute to the fragil-
ity of these integrated BACs.
Reduction of BAC Copy Number Reduces
but Does Not Eliminate Fragility
To address the possibility that the observed
instability at the integration sites could be entirely
due to the copy number of the integrated BACs
and not sequence content, we reduced the copy
number of the integrated BACs in five cell clones.
To achieve this, we took advantage of the LoxP
sites flanking the genomic inserts in the BACs.
Cell clones containing multiple copies of the inte-

























2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1
Control 2H 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
412D20-R 6H1 2 1 5 4 0 1 0 1 0 0 0 0 0 0 7 7
4H 2 6 0 0 0 0 0 0 1 1 0 0 0 0 3 7
3H5 1 2 0 0 0 0 0 0 0 0 0 0 0 0 1 2
Control 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
250G12 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
FRA3B 7H 3 1 0 0 0 0 0 1 2 11 0 0 0 0 5 13
431E5 11M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4M 2 3 0 0 0 0 1 0 0 6 0 0 0 1 3 10
8L 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 2
FRA3B 24H3 4 7 0 0 0 3 3 3 3 6 4 4 0 0 14 23
530G4 1H 2 2 0 0 0 0 0 0 0 0 0 0 0 0 2 2
Total 16 22 5 4 0 4 4 6 6 25 4 4 0 1 35 66
Number of metaphases containing:
aFISH signal on a dicentric chromosome.
bFISH signal on a ring chromosome.
cMore than one FISH signal on a ring chromosome.
dMore than one FISH signal on a single chromosome.
eVery large amplifications of FISH signal on a single chromosome.
fExtra chromosomal elements marked by FISH signal.
gFISH signal at fused sister chromatids.
TABLE 3. Copy Number Analysis for All PCR Markers
Across All BAC Clones
BAC Clone PCR 1 PCR 2 PCR 3 Avg
Control 2H 12 6 3 22 6 6 10 6 4 14
412D20 6H1 47 6 14 14 6 2 18 6 4 27
4H 1696 13 120 6 11 2106 24 166
3H5 1886 39 219 6 56 2046 37 204
Control 2 46 2 36 1 26 0.5 3
250G12 3 1466 29 90 6 11 43 6 4 93
FRA3B 7H 45 6 11 26 6 6 45 6 9 38
431E5 11M 1386 38 80 6 14 54 6 6 91
4M 2456 107 131 6 85 1286 42 168
8L 4216 240 216 6 66 3126 92 316
FRA3B 24H3 73 6 3 44 6 18 65 6 21 61
530G4 1H 90 6 32 141 6 40 87 6 29 106
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grated BACs were treated with a retrovirus
expressing Cre recombinase to induce deletion of
intervening human genomic sequences. These
cells were then sub-cloned and the resulting clones
were analyzed using Q-PCR on genomic DNA as
earlier. Using this method, we were able to clone
and identify one reduced cell clone derived from
both the control BAC 412D20 cell clone 6H1 and
the control BAC 250G12 cell clone 3. Two reduced
cell clones derived from the FRA3B BAC 431E5
cell clones 11M and 4M and one reduced cell clone
derived from the FRA3B BAC 530G4 clone 1H
were also identified. The BAC copy numbers in
the reduced control BAC clones were reduced
from 27 and 93 copies to six and two copies,
respectively (Table 4). The reduced FRA3B BAC
cell clones were reduced from 91 and 168 to three
and four copies respectively, and finally, the
reduced clone derived from the FRA3B BAC
530G4 clone 1H was reduced from 106 to two cop-
ies (Table 4). With the exception of PCR marker
No. 3 in the reduced control BAC 412D20 clone
6H1, all the three PCR markers used to determine
copy number were present in approximately equal
amounts in the reduced cell clones, suggesting that
in the reduced clones the BACs are present as
whole units.
We analyzed 75 metaphases from these reduced
clones for gaps and breaks at the site of BAC inte-
gration by FISH. All data were normalized with
respect to total gaps and breaks per metaphase. In
the absence of APH, no reduced clone showed any
gaps or breaks at the BAC integration site (Fig. 5a).
When treated with 0.4 lM APH, all three reduced
FRA3B BAC clones showed a somewhat lower fre-
quency of gaps and breaks as compared to the
unreduced clones, but still contained a significantly
increased frequency of gaps and breaks when com-
pared with the treated reduced control clones (P
value range 0.0003–0.024) (Fig. 5b). When treated
with 0.4 lM APH, none of the reduced control cell
clones showed any gaps or breaks at the site of
integration suggesting that the small number of
breaks seen in the original clones are most likely a
result of copy number (Fig. 5b). In addition, the
reduced cell clones containing integrated FRA3B
BACs showed a similar level of breakage at the
integration site when compared with the endoge-
nous FRA3B loci following 0.4 lM APH treatment
(Fig. 5c). These results demonstrate that even at a
few copies, the sequence contained in the two
FRA3B BACs was able to confer fragile site-like
instability to the ectopic site of integration.
TABLE 4. Copy number for All PCR Markers in the
Reduced Clones
BAC Clone PCR 1 PCR 2 PCR 3 Avg
Control 6H1 3 6 2 36 1 146 4 6
412D20
Control 3 16 0.4 26 1 26 1 2
250G12
FRA3B 11M 3 6 1 26 0.3 46 0.4 3
431E5 4M 66 3 36 0.9 36 0.7 4
FRA3B 1H 2 6 0.3 26 0.4 26 0.5 2
530G4
Figure 5. Cells containing FRA3B BAC integrations with reduced
copy numbers show elevated gaps and breaks at the integration site
when treated with 0.4 lm APH. All APH treated samples were normal-
ized relative to total gaps and breaks. The copy number for each clone
is indicated. (A) Percent of integration sites broken as seen in fifty
untreated metaphases for each clone. (B) The relative percentage of
gaps and breaks at the site of integration after treatment with 0.4 lm
APH as found in both the original clones containing multiple BAC copy
numbers and the reduced clones. (C) Relative percentage of gaps and
breaks at both the integration site and the endogenous FRA3B locus
for each reduced clone.
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Integrated FRA3B BACs Replicate Earlier than
Endogenous FRA3B Loci
Late replication has been demonstrated for a
number of CFSs and is believed to be a causal fac-
tor in their fragility (Le Beau et al., 1998; Wang et
al., 1999; Focarelli et al., 2006). To determine if
our integrated FRA3B BACs replicate at the same
time as the endogenous FRA3B loci, we examined
by FISH analysis 108 interphase cells from all
three cell clones containing reduced FRA3B BAC
insertions. The endogenous FRA3B site was found
to have similar replication timing in all three of the
reduced clones with doublet signals, indicative of
completed replication, observed at 27–35% of the
loci scored (Fig. 6). This frequency of replicated
loci is consistent with the previously reported late
replication timing of FRA3B (Le Beau et al.,
1998). In contrast, the integrated FRA3B BAC
sequences showed a significantly higher (P <
0.0001) percentage of doublet signals across all
three cell clones (Fig. 6). The reduced FRA3B
BAC 431E5 cell clones 4M and 11M showed dou-
blet signals at 55% and 59% of their integration
sites, respectively. The reduced BAC 530G4 cell
clone 1H had doublet signals at 74% of its integra-
tion sites, approximately a two to threefold
increase in the number of signals that are repli-
cated over the endogenous FRA3B. These data
show that the integrated BAC sequences are com-
pleting replication much earlier than the endoge-
nous FRA3B loci, yet still show the fragile site-like
instability.
DISCUSSION
We have shown that in human cells sequences
from two adjacent FRA3B BACs can transfer CFS-
like instability to new loci in the genome. These
data show that sequences taken from different
regions of the FRA3B CFS are inherently unstable
and that these sequences alone are sufficient to re-
capitulate much of the instability seen at CFSs.
Because all of the FRA3B BAC integration sites
were at unique chromosomal loci and retained sim-
ilar levels of CFS-like instability, the genomic loca-
tion of the BAC integrations does not appear to be
a significant factor in the these experiments.
Although not statistically significant, cell clones
containing integrated FRA3B BACs followed a
trend whereby the greater the BAC copy number
the greater the frequency of metaphases with
gaps and breaks at the sites of integration. This
was seen when comparing the fragility of the
original FRA3B BAC cell clones that contained
multiple BAC copies to each other (Fig. 3b),
when original and reduced cell clones were com-
pared to each other (Fig. 5b), or when any of the
FRA3B BAC cell clones was compared to the en-
dogenous FRA3B loci in the same cell clone
(Figs. 3c and 5c).
Gaps and breaks at CFSs have been shown to
lead to the BFBC and intrachromosomal gene
amplification events in Chinese hamster ovary cells
and in cancer cells (Kuo et al., 1994; Coquelle et
al., 1997, 2002). We found that the transfer of frag-
ile site sequence is sufficient to recapitulate some
of the amplification events that have been seen at
endogenous CFS loci in other studies. Clones con-
taining ectopic FRA3B BAC integrations displayed
a statistically greater overall number of chromo-
somal rearrangements and a greater number of
rearrangements indicative of BFBC than the con-
trol BAC integrations. These chromosomal rear-
rangements were not found in any of the cell
clones that were reduced in copy number, suggest-
ing that the copy number of BAC integrations is
important in the formation of these rearrange-
ments. However, the statistically significant differ-
ence in the number and type of rearrangements
between FRA3B and control BAC integrations
indicates that the sequence content of the FRA3B
BACs also contributes to these rearrangements.
The search for a discrete sequence motif that is
responsible for CFS fragility has historically been
complicated by the large size of the CFS regions.
Although we reduced the amount of sequence that
we needed to interrogate, from 1 Mb to just over
100 kb, we were not able to precisely identify a
sequence motif responsible for CFS fragility. In
addition to the AT-rich flexibility peaks (Mishmar
et al., 1998), recent work in a yeast model system
Figure 6. The percent of interphase FISH signals seen as doublets
for both the integrated BAC and the two endogenous FRA3B loci in
cells containing BAC insertions with reduced copy numbers. 108 inter-
phase cells were scored for each clone and treatment.
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has shown that short (AT)5–34 perfect repeats
within CFSs are hot spots for chromosome break-
age and that the longer of these repeats (AT)23–34
lead to stalled replication in 2D-gel analysis
(Zhang and Freudenreich, 2007). It has also been
hypothesized that the other sequence motifs capa-
ble of forming a strong secondary structures or
stalling replication could be causal in the formation
of gaps and breaks at CFSs (Durkin and Glover,
2007; Mirkin and Mirkin, 2007; Zhang and Freu-
denreich, 2007). Because both the control and the
FRA3B BACs contain similar AT content, repeti-
tive element content, tandem repeats, and palin-
drome motifs, it is unlikely that the presence of
these features alone are responsible for the differ-
ences in the instability observed at the ectopic
integrations. In addition, inverted repeats are pres-
ent in control BAC 412D20 at a frequency that is
approximately four times that of the FRA3B BACs
suggesting that this motif is not sufficient to reca-
pitulate CFS-like instability at an ectopic location.
Both AT perfect repeats greater than or equal to
(AT)5 and flexibility peaks are present at the same
frequency in the control BAC 250G12 as in both of
the FRA3B BACs suggesting that presence of
these motifs alone is also not responsible for the
fragility of these ectopic FRA3B BAC integrations.
However, it should be noted that although the fre-
quency of greater than five perfect AT repeats was
similar, the longest perfect AT repeat found in the
control BACs was an (AT)19 repeat, whereas the
longest motif in the FRA3B BACs was an (AT)24
repeat found in the overlapping region of the two
FRA3B BACs. Given that, it has been found that
AT perfect repeats (AT)21–34 units in size were
found to stall replication forks better (Zhang and
Freudenreich, 2007) and to form stronger cruci-
form structures in yeast (Dayn et al., 1991) than do
sequences with a lower number of repeats, there
may be some threshold effect whereby an (AT)19
repeat is not sufficient to contribute to fragility
whereas an (AT)24 repeat is. An examination of the
human genome reveals that there are thousands of
perfect (AT)24 repeats, many of which are not asso-
ciated with CFSs. Two of these sites, located at
9q21 and 15q25, were examined using the Twist-
Flex program. Like the (AT)24 repeat found in our
FRA3B BACs, these repeats were also found to be
located in the flexibility peaks and surrounded by
regions of high AT content (>60%). Because these
repeats were found in nonfragile regions of the
genome, and were indistinguishable from the
(AT)24 repeat found in our FRA3B BACs in size or
sequence context, it is suggested that although a
single (AT)24 may be contributory to the fragility
of CFSs, the contribution of sequence to the insta-
bility of our BAC integrations, and to CFSs in gen-
eral, is likely to be more complex.
Although a number of studies have reported that
molecularly characterized CFS are highly flexible
and AT rich (Boldog et al., 1997; Mishmar et al.,
1998; Ried et al., 2000; Shiraishi et al., 2001; Arlt
et al., 2002; Limongi et al., 2003; Ferber et al.,
2004), a few studies differ in their findings. Helm-
rich et al., examined sequences from 15 human
and eight mouse CFSs and found no increase in
DNA flexibility when compared with the controls
(Helmrich et al., 2006). Similarly, Tsantoulis et al.,
describes CFSs as being flexibility peak poor and
GC rich (Tsantoulis et al., 2008). Both of these
studies included large regions of sequence flanking
the CFSs in their analyses, as opposed to a few
hundred kilobases of most fragile DNA at the cen-
ter of molecularly characterized CFSs as in most
other studies of CFS sequence. In addition, Tsan-
toulis et al. included CFSs that have only been
mapped at the resolution of a chromosome band in
their analysis. These disparities likely account for
the differences in findings and interpretations.
A few studies have explored the contribution of
sequence to CFS instability by examining chromo-
some breakage at endogenous CFSs that contain
large deletions. Hamster human chromosome 3-
hybrid cell clones containing large deletions of
FRA3B derived during tumorigenesis were found
to have no significant reduction in fragility (Corbin
et al., 2002). More recently, a significant reduction
in the fragility of FRA3B was reported in seven
clones with large (several hundred kilobases) APH-
induced deletions centered within the fragile site
(Durkin et al., 2008). Many of these deletions
encompass the sequences contained in our FRA3B
BACs. Finally, a tumor cell line containing a dele-
tion of the entire FRAXB locus was found to have
completely lost fragility of FRAXB (Arlt et al.,
2002). These findings suggest that many sequence
motifs spread throughout the region are likely to
contribute to the fragility of CFSs and are in agree-
ment with our results that the two adjoining
regions of FRA3B were capable of recapitulating
CFS-like instability at ectopic sites. Furthermore,
these findings imply that whatever features are
necessary for CFS fragility are located within the
defined CFS sequence boundaries and cannot be
eliminated without a complete deletion of the site.
To examine other factors that could contribute
to CFS fragility, we analyzed the integrated BACs
in our reduced clones for replication timing. It was
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found that ectopic FRA3B BAC integrations were
2–3 times more likely than the endogenous
FRA3B sites to be replicated. Despite earlier repli-
cation timing, these sites were still unstable and
formed gaps and breaks under conditions of repli-
cation stress. These findings suggest that ectopic
FRA3B BAC integrations do not need to be as late
replicating as the endogenous loci to be unstable.
Because these findings were determined using a
FISH assay with the entire FRA3B BACs as
probes, we cannot exclude the possibility that
smaller regions within the integrated BACs are late
replicating. However these data suggest that late
replication is not necessary for the formation of
gaps and breaks at our FRA3B ectopic integra-
tions.
Our findings show that sequence alone is a criti-
cal factor underlying the instability seen at CFSs,
and may help to elucidate further mechanisms
involved in CFS instability. While it has long been
hypothesized that specific sequences are causal to
the fragility of CFSs, this is the first example show-
ing that CFS instability can be transferred to ec-
topic sites in mammalian cells by more than one
region and that this instability can be seen with as
little as 300 kb of transferred sequence. These
findings are central to understanding the funda-
mental mechanisms underlying CFS instability,
the role of CFSs in the normal functioning of
human cells, and in early breakage events in tu-
morigenesis.
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